MENU
EYPT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
EyePoint (EYPT) Earnings Date & Reports
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care... Show more
Industry: #Pharmaceuticals Major
A.I. Advisor
published Earnings
EYPT is expected to report earnings to fall 19.27% to -87 cents per share on November 04
Q3'26
Est.
$-0.88
Q2'26
Missed
by $0.15
Q1'26
Missed
by $0.17
Q4'25
Missed
by $0.06
Q3'25
Missed
by $0.08
The last earnings report on August 05 showed earnings per share of -109 cents, missing the estimate of -93 cents. With 2.38M shares outstanding, the current market capitalization sits at 32.31M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a developer of ophthalmic pharmaceuticals
Industry Biotechnology
Industry
Pharmaceuticals Major
Address
480 Pleasant Street
Phone
+1 833 393-7646
Employees
214
Web
https://www.eyepoint.bio